<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q/A
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1996
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 0-21022
SHAMAN PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 94-3095806
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
213 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA 94080
(Address of principal executive offices and zip code)
(415) 952-7070
(Registrant's telephone number, including area code)
- --------------------------------------------------------------------------------
Former Name, Former Address and Former Fiscal Year,
if Changed Since Last Report.
Indicate by check [X] whether the registrant (1) has filed all
reports required to be filed by Sections 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes [X] No
--- ---
Number of shares of Common Stock, $0.001 par value, outstanding as of June 30,
1996: 13,389,320.
<PAGE> 2
ITEM 6: Exhibits and Reports on Form 8-K
(a) Exhibits
10.49* Subscription Agreement, dated July 25, 1996, by and
between Fletcher International Limited and the
Company.
- -------------------
* Confidential treatment pursuant to Rule 24b-2 under the Securities Exchange
Act of 1934 as amended has been granted with respect to certain portions of this
agreement.
(b) There were no reports on Form 8-K during the quarter ended June
30, 1996.
2.
<PAGE> 3
SHAMAN PHARMACEUTICALS, INC.
SIGNATURES
Pursuant to the Requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
SHAMAN PHARMACEUTICALS, INC.
(Registrant)
Date: December 9, 1996 By: /s/ Lisa A. Conte
--------------------------------------------
Lisa A. Conte
President and Chief Executive Officer
(Principal Executive Officer)
By: /s/ Barbara J. Goodrich
--------------------------------------------
Barbara J. Goodrich
Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
3.
<PAGE> 1
SUBSCRIPTION AGREEMENT
This Subscription Agreement (the "Agreement"), dated July 25, 1996 is
entered into by and between Shaman Pharmaceuticals, Inc., a Delaware corporation
("Shaman"), and Fletcher International Limited, a company organized under the
laws of the Cayman Islands ("Fletcher").
Unless otherwise defined herein, capitalized terms used herein and not
defined herein shall have the meanings given to them in Regulation S
("Regulation S") under the Securities Act of 1933, as amended (the "Securities
Act").
The parties hereto agree as follows:
1. Purchases and Sale. In consideration of and upon the basis of the
representations, warranties and agreements and subject to the terms and
conditions set forth in this Agreement:
a. Series A Preferred Stock. Shaman agrees to sell to Fletcher,
and Fletcher agrees to purchase from Shaman, on the Closing Date
specified in Section 2 hereof, 400,000 newly issued shares of its
Series A Preferred Stock, par value $0.001 per share, of Shaman (the
"Preferred Shares"), at a price per share equal to $8.147. As used
herein, the term "Trading Day" means any day on which Shaman's Common
Stock, par value $0.001 per share (the "Common Stock") is quoted on the
National Association of Securities Dealers Automated Quotation
("NASDAQ") System.
b. Put Options. Fletcher agrees to grant to Shaman on the
Closing Date specified in Section 2 hereof, six put options having the
terms set forth in Annex A hereto (each a "Put Option").
c. Warrant. Shaman agrees to sell to Fletcher, and Fletcher
agrees to purchase from Shaman, on the Closing Date specified in
Section 2 hereof, a warrant having the terms set forth in Annex B
hereto (the "Warrant") to purchase an aggregate of 550,000 shares of
Common Stock which, in accordance with the terms and conditions of this
Agreement, will be freely tradable. The shares of Common Stock issuable
pursuant to the Warrant are referred to herein as the "Warrant Shares."
2. Closing. The delivery of the Preferred Shares referred to in
Section 1(a) and the Warrant referred to in Section 1(c) and payment therefor
(the "Closing") shall take place at 3:00 p.m. (New York time) on July 26, 1996,
or at such other date and time as Fletcher and Shaman may agree in writing (such
date and time being referred to herein as the "Closing Date").
<PAGE> 2
At the Closing, the following deliveries shall be made:
a. Preferred Shares. Shaman shall deliver the certificate or
certificates representing the Preferred Shares referred to in Section
1(a) to Fletcher, at such address as shall be specified by Fletcher,
duly registered in the name of Fletcher.
b. Warrant. Shaman shall deliver the certificate or certificates
representing the Warrant to Fletcher. Such certificates shall be
substantially in the form attached hereto as Annex B hereto.
c. Officers' Certificate. Shaman shall deliver the officers'
certificate required by Section 7(a).
d. Legal Opinions. The legal opinions required by Sections 7(b)
and 8(b) shall be delivered to Fletcher and Shaman, respectively.
e. Payment. Payment of the Preferred Stock Purchase Price shall
be made by Fletcher by New York Clearing House (next day) funds to the
following Shaman account (subject to customary settlement procedures):
Client Account No. 449-15852-14025
Subaccount of Smith Barney Account No. 066-198-038
Chemical Bank (ABA No. 021000128).
The foregoing deliveries shall be deemed to occur simultaneously as
part of a single transaction, and no delivery shall be deemed to have been made
until all such deliveries have been made.
3. Representations and Warranties of Shaman. Shaman hereby represents
and warrants to Fletcher on the date hereof, on the Closing Date, on the date
any Preferred Share is converted (each a "Preferred Share Conversion Date"), on
each Put Option Exercise Date (as defined in Annex A hereto) and on each Warrant
Exercise Date (as defined in Annex B hereto) as follows:
a. Shaman has been duly incorporated and is validly existing in
good standing under the laws of Delaware.
b. This Agreement has been duly authorized, executed and
delivered by Shaman and, when duly authorized, executed and delivered
by Fletcher, will be a valid and binding agreement enforceable against
Shaman in accordance with its terms, subject to bankruptcy, insolvency,
fraudulent transfer, reorganization, moratorium and similar laws of
general applicability relating to or affecting creditors' rights
generally and to general principles of equity.
2.
<PAGE> 3
c. Shaman has full corporate power and authority necessary to
enter into this Agreement and to perform its obligations hereunder.
d. No consent, approval, authorization or order of any court,
governmental agency or other body is required for execution by Shaman
of this Agreement or the performance by Shaman of any of its
obligations hereunder.
e. Neither the execution by Shaman of this Agreement nor the
performance by Shaman of any of its obligations hereunder will:
(1) violate, conflict with, result in a breach of, or
constitute a default (or an event which with the giving of notice or
the lapse of time or both would be reasonably likely to constitute a
default) under (A) the Restated Certificate of Incorporation, by-laws
or any other constitutive document of Shaman or any of its affiliates,
(B) any decree, judgment, order, law, treaty, rule, regulation or
determination of which Shaman is aware (after due inquiry) of any
court, governmental agency or body, or arbitrator having jurisdiction
over Shaman or any of its affiliates or any of their respective
properties or assets, (C) the terms of any bond, debenture, note or any
other evidence of indebtedness, or any agreement, stock option or other
similar plan, indenture, lease, mortgage, deed of trust or other
instrument to which Shaman or any of its affiliates is a party, by
which Shaman or any of its affiliates is bound, or to which any of the
properties or assets of Shaman or any of its affiliates is subject, or
(D) the terms of any "lock-up" or similar provision of any underwriting
or similar agreement to which Shaman or any of its affiliates is a
party; or
(2) result in the creation or imposition of any lien, charge
or encumbrance upon (A) any Preferred Share, the Warrant or any Common
Stock or (B) any of the properties or assets of Shaman or any of its
affiliates.
f. When issued to Fletcher against payment therefor in
accordance with the terms of this Agreement, any Preferred Share, any
Put Option or the Warrant, each share of Common Stock:
(1) will have been duly and validly authorized, duly and
validly issued, fully paid and non-assessable;
(2) will be free and clear of any security interests, liens,
claims or other encumbrances; and
(3) will not have been issued or sold in violation of any
preemptive or other similar rights of the holders of any securities of
Shaman.
3.
<PAGE> 4
g. When any share of Common Stock is issued to Fletcher pursuant to
the terms of this Agreement, any Preferred Share, any Put Option or the Warrant,
the Common Stock will be quoted on NASDAQ or listed and registered on a national
securities exchange (as defined in the United States Securities Exchange Act of
1934, as amended (the "Exchange Act")).
h. Shaman is a Reporting Issuer within the meaning of Regulation S.
i. There is no pending or, to the best knowledge of Shaman,
threatened action, suit, proceeding or investigation before any court,
governmental agency or body, or arbitrator having jurisdiction over Shaman or
any of its affiliates that would materially affect the execution by Shaman of,
or the performance by Shaman of its obligations under, this Agreement, provided,
however, that the representations and warranties contained in this Section 3(i)
shall not apply to any action, threatened action, suit, proceeding or
investigation initiated by Fletcher and shall not be required to be given in
respect of any Preferred Share Conversion Date or Warrant Exercise Date.
j. None of Shaman's filings with the United States Securities and
Exchange Commission (the "S.E.C.") under the Securities Act or under Section
13(a) or 15(d) of the Exchange Act (each, an "SEC Filing"), or press releases
material to the business of Shaman as a whole, contain any untrue statement of a
material fact or omit to state any material fact necessary in order to make the
statements, in the light of the circumstances under which they were made, not
misleading.
k. Since the date of Shaman's most recent SEC Filing, there has not
been, and Shaman is not aware of any development that might result in, any
material adverse change in the condition, financial or otherwise, or in the
business affairs or business prospects of Shaman, whether or not arising in the
ordinary course of business, except as disclosed in such SEC Filing, provided,
however, that the representations and warranties contained in this Section 3(k)
shall not be required to be given in respect of any Preferred Share Conversion
Date or Warrant Exercise Date.
l. The offer and sale of the Preferred Shares, the Common Stock, the
Warrant and the Warrant Shares to Fletcher pursuant to this Agreement will,
subject to compliance by Fletcher with the applicable representations and
warranties contained in Section 4 hereof and with the applicable covenants and
agreements contained in Section 6 hereof, be made in accordance with the
provisions and requirements of Regulation S and any applicable state law.
m. Neither Shaman nor any of its affiliates nor any person acting on
its or their behalf has engaged or will engage in any Directed Selling Efforts
with respect to the Preferred Shares, the Common Stock, the Warrant or the
Warrant Shares, and all such persons understand and have complied and will
otherwise comply with the requirements of Regulation S.
4.
<PAGE> 5
n. The transactions contemplated by this Agreement are not part of a
plan or scheme on the part of Shaman, any of its affiliates or any person acting
on its or their behalf to evade the registration provisions of the Securities
Act.
o. Shaman has not issued, and after the Closing Date will not issue,
any stop transfer order or other order impeding the sale and delivery of the
Preferred Shares, the Common Stock, the Warrant or the Warrant Shares issuable
hereunder except for a stop order restricting the sale of any of the foregoing
securities to any person in the United States or to or for the account or
benefit of any U.S. Person during an applicable Restricted Period.
Notwithstanding the foregoing provision, Shaman shall place the following legend
on the certificate representing any security issued hereunder prior to the
expiration of the Restricted Period (as defined herein) applicable to such
security:
The securities represented by this certificate were issued on July 26,
1996 (the "Original Issue Date") pursuant to the Subscription Agreement
dated July 25, 1996 between Shaman Pharmaceuticals, Inc. ("Shaman") and
Fletcher International Limited. The securities represented by this
certificate have not been registered under the Securities Act of 1933,
as amended (the "Securities Act"), and have been sold in reliance on
the exemption from registration provided by Regulation S under the
Securities Act ("Regulation S"). Prior to the expiration of a 40-day
restricted period beginning on the Original Issue Date (the "Restricted
Period"), the securities represented by this certificate may not be
offered or sold, directly or indirectly, within the United States (as
defined in Regulation S under the Act), to a U.S. Person (as defined in
Regulation S under the Act) or for the account or benefit of a U.S.
Person. Neither Shaman Pharmaceuticals, Inc. nor its transfer agent
shall be obligated to remove this legend unless it shall have received
an opinion of counsel stating that such removal complies with the
requirements of Regulation S (under the Act).
provided, however, that as used in this Agreement and as reflected in such
legend, the term "Restricted Period," with respect to any security, shall mean
the Restricted Period then applicable to such security pursuant to Regulation S
(or any applicable successor thereto).
p. Neither Shaman nor any of its affiliates has offered to sell or
sold any Common Stock or any securities convertible or exchangeable into or
exercisable for Common Stock in reliance upon Regulation S at any time during
the past 12 months; and there are no outstanding convertible or exchangeable
securities that have been offered or sold in reliance upon Regulation S, except,
in each case the Warrant and the Preferred Shares sold pursuant hereto.
5.
<PAGE> 6
q. (i) If, any time after the date hereof, the S.E.C. has
reinterpreted Regulation S or has promulgated, or the United States Congress has
legislated, a successor or revision to Regulation S, and such reinterpretation,
successor provision or revision imposes a Restricted Period applicable to any
security issued or issuable hereunder that is greater than that in effect on the
date of this Agreement, or would materially impair the ability of Fletcher or
any of its affiliates (as defined in Rule 144(a) under the Securities Act) to
offer, sell or otherwise dispose of any such security pursuant to Regulation S
as contemplated hereby, or requires any such offer, sale or other disposition to
be registered under the Securities Act, then upon the written request of
Fletcher (a "Registration Request"), Shaman shall, as promptly as practicable
thereafter and at its own expense, file a registration statement (the
"Registration Statement") under the Securities Act covering the sale or resale
of all such securities (each a "Covered Security"); provided, however, that in
no event shall Shaman be required to file a Registration Statement or otherwise
comply with a Registration Request to the extent that such reinterpretation,
successor provision or revision imposes limitations on the offer, sale or other
disposition of any Covered Security by Fletcher pursuant to Regulation S solely
as a result of Fletcher's hedging or selling short such Covered Security or
engaging in any other activity the effect of which is to decrease or limit
Fletcher's investment risk with respect to such Covered Security in violation of
such reinterpretation, successor provision or revision. Prior to the
effectiveness of such Registration Statement, Shaman shall not be entitled to
exercise any Put Option under this Agreement. Upon the effectiveness of such
Registration Statement (A) Shaman shall issue such securities to Fletcher in
accordance with the terms hereof, (B) the provisions of Sections 3(l), (m) and
(o), 4(e), (f), (g), (h), (i) and (j), 5(a), (b), (c) and (d), 6(a)
(collectively, the "Specified Provisions"), 7(a) and (b) (to the extent
applicable to the Specified Provisions), 8(b), (c) and (d) (to the extent
applicable to the Specified Provisions) shall thereafter be of no force and
effect with respect to the issuance of such Covered Securities and (C) the
provision that not more than one Put Option shall be exercisable within any
six-month period shall be of no further force and effect, and with respect to
any Put Options outstanding at that time, not more than one such Put Option
shall be exercisable within any 50 Trading Day period and no such Put Option
shall be exercisable to the extent that (i) the number of shares of Common Stock
issuable to Fletcher pursuant to such Put Option plus (ii) the number of shares
of Common Stock issued to Fletcher during the immediately preceding 365 days
pursuant to any Put Option plus (iii) the total number of shares of Common Stock
issuable to Fletcher pursuant to the Preferred Shares (whether or not such
Preferred Shares have been converted) plus (iv) the total number of Warrant
Shares issuable to Fletcher pursuant to the Agreement (whether or not such
Warrant Shares have then been issued), would equal or exceed 10% of the number
of shares of Common Stock outstanding on the relevant Put Option Exercise Date
(including common stock issuable under (iii) or (iv) above), provided, however,
that, if such Registration Statement has not been declared effective before the
180th day following the date of such Registration Request, then (X) any Put
Options outstanding under this Agreement shall immediately expire and shall not
thereafter be exercisable, and Fletcher shall have no further liability
whatsoever with respect thereto
6.
<PAGE> 7
and (Y) Shaman shall use its best efforts to cause such Registration Statement
to become effective as promptly as practicable in respect of any outstanding
portion of the securities the sale or resale of which is required to be so
registered.
(ii) In the case of the registration effected by Shaman pursuant
to this Section 3(q) registration provisions, Shaman will use its best efforts
to: (i) keep such registration effective until the earlier of (A) the third
anniversary of the issuance of each Covered Security, (B) such date as all of
the Covered Securities have been sold by Fletcher or (C) such time as all of the
Covered Securities held by Fletcher can be sold by Fletcher or any of its
affiliates (within the meaning of Rule 144(a) under the Securities Act) within a
given three-month period without compliance with the registration requirements
of the Securities Act pursuant to Rule 144 under the Securities Act ("Rule
144"); (ii) prepare and file with the S.E.C. such amendments and supplements to
the Registration Statement and the prospectus used in connection with the
Registration Statement (as so amended and supplemented from time to time, the
"Prospectus") as may be necessary to comply with the provisions of the
Securities Act with respect to the disposition of all Covered Securities by
Fletcher or any of its affiliates (within the meaning of Rule 144(a) under the
Securities Act); (iii) furnish such number of Prospectuses and other documents
incident thereto, including any amendment of or supplement to the Prospectus, as
Fletcher from time to time may reasonably request; (iv) cause all Covered
Securities that are Common Stock to be listed on each securities exchange and
quoted on each quotation service on which similar securities issued by Shaman
are then listed or quoted; (v) provide a transfer agent and registrar for all
Covered Securities and a CUSIP number for all Covered Securities; (vi) otherwise
use its best efforts to comply with all applicable rules and regulations of the
S.E.C.; and (vii) file the documents required of Shaman and otherwise use its
best efforts to obtain and maintain requisite blue sky clearance in (A) all
jurisdictions in which any of the Covered Securities are originally sold and (B)
all other states specified in writing by Fletcher, provided as to clause (B),
however, that Shaman shall not be required to qualify to do business or consent
to service of process in any state in which it is not now so qualified or has
not so consented.
(iii) Shaman shall furnish to Fletcher upon request a reasonable
number of copies of a supplement to or an amendment of such Prospectus as may be
necessary in order to facilitate the public sale or other disposition of all or
any of the Covered Securities by Fletcher or any of its affiliates (within the
meaning of Rule 144(a) under the Securities Act); pursuant to the Registration
Statement.
(iv) With a view to making available to Fletcher and its
affiliates (within the meaning of Rule 144(a) under the Securities Act) the
benefits of Rule 144 and Form S-3 under the Securities Act, Shaman covenants and
agrees to: (i) make and keep available adequate current public information
(within the meaning of Rule 144(c)) concerning Shaman, until the earlier of (A)
the third anniversary of the issuance of each Covered Security of (B) such date
as all of the Covered Securities shall have been resold
7.
<PAGE> 8
by Fletcher or any of its affiliates (within the meaning of Rule 144(a) under
the Securities Act); (ii) maintain its status as a Reporting Issuer and file
with the S.E.C. in a timely manner all reports and other documents required of
Shaman for use of Form S-3; and (iii) furnish to Fletcher upon request, as long
as Fletcher owns any Covered Securities (A) a written statement by Shaman that
it has complied with the reporting requirements of the Securities Act and the
Exchange Act, (B) a copy of the most recent annual or quarterly report of
Shaman, and (C) such other information as may be reasonably requested in order
to avail Fletcher and its affiliates (within the meaning of Rule 144(a) under
the Securities Act) of Rule 144 or Form S-3 with respect to such Covered
Securities.
(v) Notwithstanding anything else in this Section 3(q), if, at
any time during which a Prospectus is required to be delivered in connection
with the sale of any Covered Securities, Shaman determines in good faith that a
development has occurred or a condition exists as a result of which the
Registration Statement or the Prospectus contains a material misstatement or
omission, Shaman will immediately notify Fletcher thereof by telephone and in
writing. Upon receipt of such notification, Fletcher and its affiliates (within
the meaning of Rule 144(a) under the Securities Act) will immediately suspend
all offers and sales of any Covered Securities pursuant to the Registration
Statement. In such event, Shaman will amend or supplement the Registration
Statement as promptly as practicable and will take such other steps as may be
required to permit sales of the Covered Securities thereunder by Fletcher and
its affiliates (within the meaning of Rule 144(a) under the Securities Act) in
accordance with applicable federal and state securities laws. Shaman will
promptly notify Fletcher after it has determined in good faith that such sales
have become permissible in such manner and will promptly deliver copies of the
Registration Statement and the Prospectus (as so amended or supplemented) to
Fletcher in accordance with paragraph (ii) of this Section 3(q). Notwithstanding
the foregoing, (A) under no circumstances shall Shaman be entitled to exercise
its right to suspend sales of any Covered Securities pursuant to the
Registration Statement more than two times in any twelve-month period, (B) the
period during which such sales may be suspended (each a "Blackout Period") shall
not exceed thirty days and (C) no Blackout Period may commence less than 30 days
after the end of the preceding Blackout Period.
Upon the commencement of a Blackout Period pursuant to this
Section 3(q), Fletcher will immediately notify Shaman of any contracts to sell
any Covered Securities (each a "Sales Contract") that Fletcher or any of its
affiliates (within the meaning of Rule 144(a) under the Securities Act) has
entered into prior to the commencement of such Blackout Period and that would
require delivery of such Covered Securities during such Blackout Period, which
notice will contain the aggregate sale price and volume of Covered Securities
pursuant to such Sales Contract. Upon receipt of such notice, Shaman will
immediately notify Fletcher of its election either (i) to terminate the Blackout
Period and, as promptly as practicable, amend or supplement the Registration
Statement or the Prospectus in order to correct the material misstatement or
omission and
8.
<PAGE> 9
deliver to Fletcher copies of such amended or supplemented Registration
Statement and Prospectus in accordance with paragraph (ii) of this
Section 3(q) or (ii) to continue the Blackout Period in accordance with
this paragraph. If Shaman elects to continue the Blackout Period, and
Fletcher or any of its affiliates (within the meaning of Rule 144(a)
under the Securities Act) is therefore unable to consummate the sale of
Covered Securities pursuant to the Sales Contract (such unsold Covered
Securities being hereinafter referred to herein as the "Unsold
Securities"), Shaman will promptly indemnify each Fletcher Indemnified
Party (as such term is defined in Section 11(a) below) against any
Proceeding (as such term is defined in Section 11(a) below) that each
Fletcher Indemnified Party may incur arising out of or in connection
with Fletcher's breach or alleged breach of any such Sales Contract,
and Shaman shall reimburse each Fletcher Indemnified Party for any
reasonable costs or expenses (including reasonable legal fees) incurred
by such party in investigating or defending any such Proceeding
(collectively, the "Indemnification Amount"); provided, however, that
each Fletcher Indemnified Party shall take all actions reasonably
necessary or appropriate to mitigate such Indemnification Amount; and
provided further, however, that the Indemnification Amount shall be
reduced by an amount equal to the number of Unsold Securities
multiplied by the difference between (x) the actual per share price
received by Fletcher or any of its affiliates (within the meaning of
Rule 144(a) under the Securities Act) upon the sale of the Unsold
Securities (if such sale occurs within three Trading Days of the end of
the Blackout Period) or the closing sale price of the Common Stock on
NASDAQ or other national securities exchange on which the Common Stock
is then listed on the third Trading Day after the end of the Blackout
Period (if the Unsold Securities are not sold by Fletcher or any of its
affiliates (within the meaning of Rule 144(a) under the Securities Act)
within three Trading Days of the end of the Blackout Period), and (y)
the per share sale price for the Unsold Securities provided in the
Sales Contract.
4. Representations and Warranties of Fletcher. Fletcher hereby
represents and warrants to Shaman as follows:
a. Fletcher has been duly incorporated and is validly
existing in good standing under the laws of the Cayman Islands.
b. This Agreement has been duly authorized, executed and
delivered by Fletcher and, when duly authorized, executed and delivered
by Shaman, will be a valid and binding agreement enforceable against
Fletcher in accordance with its terms, subject to bankruptcy,
insolvency, fraudulent transfer, reorganization, moratorium and similar
laws of general applicability relating to or affecting creditors'
rights generally and to general principles of equity.
c. Fletcher understands that no United States federal or
state agency has passed on, reviewed or made any recommendation or
endorsement of the Preferred Shares, the Common Stock, the Warrant or
the Warrant Shares;
9.
<PAGE> 10
d. In making the decision to purchase the Preferred Shares,
the Common Stock, the Warrant and the Warrant Shares in accordance with
this Agreement, Fletcher has relied solely upon independent
investigations made by it and not upon any representations made by
Shaman other than those made pursuant to this Agreement.
e. Fletcher understands that the Preferred Shares, the Common
Stock, the Warrant and the Warrant Shares have not been and will not be
registered under the Securities Act and may not be reoffered or resold
other than pursuant to such registration or an available exemption
therefrom.
f. Fletcher is not a U.S. Person and is not acquiring the
Preferred Shares, the Common Stock, the Warrant or any Warrant Shares
for the account or benefit of any U.S. Person, and Fletcher is not an
affiliate (within the meaning of Rule 144 under the Securities Act) of
Shaman.
g. At the time the buy orders for the Preferred Shares and
the Warrant (and any Common Stock and Warrant Shares issued during the
applicable Restricted Period) were originated, Fletcher was located
outside the United States.
h. Neither Fletcher nor any of its affiliates nor anyone
acting on its or their behalf has engaged or will engage in any
Directed Selling Efforts with respect to the Preferred Shares, the
Common Stock, the Warrant or any Warrant Shares, and all such persons
understand and have complied and will otherwise comply with the
requirements of Regulation S.
i. Fletcher:
(1) will not, during the Restricted Period applicable to the
Preferred Shares, the Common Stock, the Warrant and the Warrant Shares,
offer or sell any of the foregoing securities (or create or maintain
any derivative position equivalent thereto) in the United States, to or
for the account or benefit of a U.S. Person or other than in accordance
with Regulation S; and
(2) will, after the expiration of the applicable Restricted
Period, offer, sell, pledge or otherwise transfer the Preferred Shares,
the Common Stock, the Warrant or any Warrant Shares (or create or
maintain any derivative position equivalent thereto) only pursuant to
registration under the Securities Act or an available exemption
therefrom and, in any case, in accordance with applicable state
securities laws.
j. Fletcher is purchasing the Preferred Shares, the Warrant
and the Warrant Shares for its own account, for the purpose of
investment and not with a view to a distribution thereof.
10.
<PAGE> 11
k. The transactions contemplated by this Agreement are not part
of a plan or scheme on the part of Fletcher, any of its affiliates or any
person acting on its or their behalf to evade the registration
requirements of the Securities Act.
5. Covenants of Shaman. Shaman covenants and agrees with Fletcher as
follows:
a. For so long as any Preferred Share is outstanding or any of
the Put Options have not been exercised or any portion of the Warrant
remains outstanding, and in either case for a period of 40 days
thereafter, Shaman will continue to be a Reporting Issuer within the
meaning of Regulation S and will maintain the eligibility of the Common
Stock for quotation on NASDAQ or listing on a national securities exchange
(as defined in the Exchange Act).
b. For so long as any Preferred Share is outstanding or any of
the Put Options have not been exercised or any portion of the Warrant
remains outstanding, and in either case for a period of six months
thereafter, Shaman will not offer or sell any Common Stock or any
securities convertible into or exchangeable into Common Stock in reliance
upon Regulation S.
c. For so long as any Preferred Share is outstanding or any of
the Put Options have not been exercised or any portion of the Warrant
remains outstanding, and in either case for a period of 40 days
thereafter, neither Shaman nor any of its affiliates nor any person acting
on its or their behalf will engage in any Directed Selling Efforts with
respect to the Preferred Shares, the Common Stock, the Warrant or Warrant
Shares.
d. For so long as any Preferred Share is outstanding or any of
the Put Options have not been exercised or any portion of the Warrant
remains outstanding, and in either case for a period of 40 days
thereafter, Shaman will ensure that all applicable Offering Restrictions
with respect to the Preferred Shares, the Common Stock, the Warrant and
the Warrant Shares are thoroughly complied with and satisfied.
e. Beginning on the date hereof and for so long as any Preferred
Share is outstanding or any of the Put Options have not been exercised or
any portion of the Warrant remains outstanding, and in either case for a
period of 40 days thereafter, Shaman will promptly notify Fletcher if (i)
any event shall have occurred as a result of which any SEC Filing would
include an untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading, or
(ii) there is any public disclosure of material information regarding
Shaman or its financial condition prospects or results of operation.
f. At any time after the expiration of any Restricted Period
with respect to the Preferred Shares, the Common Stock, the Warrant or any
Warrant Shares,
11.
<PAGE> 12
upon the request of Fletcher accompanied by an opinion of Rogers & Wells
(or such other counsel as shall be reasonably satisfactory to Shaman and
its transfer agent (if any)) to the effect that the removal of the legend
referred to in Section 4(o) would then be permitted under Regulation S and
that the resale of any such securities would not require registration
under the Securities Act, Shaman shall, or shall cause its transfer agent
(if any) to, accept from Fletcher the legended certificates representing
such securities and deliver in their place unlegended certificates
therefor.
g. Shaman will comply with the terms and conditions of the Put
Option and the Warrant as set forth in Annex A and Annex B hereto,
respectively (as duly amended from time to time by the parties hereto),
and when issued, each Preferred Share will be substantially in the form of
Annex C hereto.
h. For so long as any Preferred Share is outstanding or any of
the Put Options have not been exercised or any portion of the Warrant
remains outstanding, Shaman shall at all times reserve and keep available,
free from pre-emptive rights, out of its authorized but unissued Common
Stock, for issuance upon conversion of such Preferred Shares and exercise
of such Put Options and Warrant, the maximum number of shares of Common
Stock then so issuable.
6. Covenants of Fletcher. Fletcher hereby covenants and agrees with
Shaman as follows:
a. During any Restricted Period applicable to the Preferred
Shares, the Common Stock, the Warrant or the Warrant Shares, neither
Fletcher nor any of its affiliates nor any person acting on its or their
behalf will:
(1) offer or sell such Preferred Shares, Common Stock,
Warrant or the Warrant Shares other than in an Offshore
Transaction;
(2) engage in any Directed Selling Efforts with respect to
such Preferred Shares, Common Stock, Warrant or Warrant Shares;
(3) offer or sell such Preferred Shares, Common Stock,
Warrant or Warrant Shares other than: (A) in accordance with Rule
903 or Rule 904 of Regulation S; (B) pursuant to registration
under the Securities Act or (C) pursuant to an available exemption
therefrom; and
(4) offer or sell such Preferred Shares, Common Stock,
Warrant or Warrant Shares to any U.S. Person or for the account or
benefit of any U.S. Person.
12.
<PAGE> 13
7. Conditions Precedent to Fletcher's Obligations. The obligations of
Fletcher hereunder are subject to the performance by Shaman of its obligations
hereunder and to the satisfaction of the following additional conditions
precedent:
a. The representations and warranties made by Shaman in this
Agreement shall, unless expressly waived in writing by Fletcher, be true
and correct on the date hereof, on the Closing Date, on each Preferred
Share Conversion Date, on each Put Option Exercise Date (as defined in
Annex A hereto) and on each Warrant Exercise Date (as defined in Annex B
hereto), and Fletcher shall have received on each such date a certificate
of the Chief Executive Officer and the Chief Financial Officer of Shaman
dated such date and to such effect.
b. On the Closing Date, on each Preferred Share Conversion Date,
on each Put Option Exercise Date (as defined in Annex A hereto) and on
each Warrant Exercise Date (as defined in Annex B hereto) Shaman shall
have delivered to Fletcher an opinion of its counsel reasonably
satisfactory to Fletcher, dated the date of delivery, confirming in
substance the matters covered in paragraphs (a), (b), (c), (d), (e), (f),
(g), (h) and (i) of Section 3 hereof; provided, however, that no such
opinion delivered in respect of any Preferred Share Conversion Date or
Warrant Exercise Date shall be required to cover the matters set forth in
paragraph (i) of Section 3 hereof.
c. On any Put Option Exercise Date, Fletcher's obligation to
purchase any shares of Common Stock hereunder shall be subject to the
additional condition that during the five (5) Business Days (as defined
below) immediately preceding such Put Option Exercise Date, Shaman shall
not have made any SEC Filing or issued any press release describing and
shall not be aware of any material adverse change, or any development that
might result in any material adverse changes in the condition, financial
or otherwise, or in the business affairs or business prospects of Shaman,
whether or not arising in the ordinary course or business; provided,
however, that if on any Put Option Exercise Date such condition has not
been satisfied, such Put Option Exercise Date and each subsequent Put
Option Exercise Date and the Put Option Termination Date hereunder shall
be postponed by five (5) Business Days for all purposes of this
Subscription Agreement as if such fifth (5th) Business Day had originally
been specified as such Put Option Exercise Date or Put Option Termination
Date, as the case may be; and provided further, however, that if, on such
fifth (5th) Business Day, such condition has not been satisfied, there
shall be no further postponement of such Put Option Exercise Date.
As used herein the term "Business Day" means any day on which banks in
The City of New York are open for business.
8. Conditions Precedent to Shaman's Obligations. The obligations of
Shaman hereunder are subject to the performance by Fletcher of its obligations
hereunder and to the satisfaction of the following additional conditions
precedent:
13.
<PAGE> 14
a. The representations and warranties made by Fletcher in this
Agreement shall, unless expressly waived in writing by Shaman, be true and
correct as of the date hereof, on the Closing Date, on each Preferred
Share Conversion Date, on each Put Option Exercise Date and on each
Warrant Exercise Date, and Shaman shall have received on each such date a
certificate of the Chief Financial Officer of Fletcher dated such date and
to such effect.
b. On the Closing Date, Fletcher shall have delivered to Shaman
a legal opinion of Rogers & Wells, counsel to Fletcher, dated the date of
delivery stating that:
(i) Fletcher is not a U.S. Person; and
(ii) The offer and sale of the Preferred Shares and the
Warrant by Shaman to Fletcher on the Closing Date does not require
registration under the Securities Act;
c. On each Preferred Share Conversion Date, Fletcher shall have
delivered to Shaman a legal opinion of Rogers & Wells, counsel to
Fletcher, dated the date of delivery, stating that:
(i) Fletcher is not a U.S. Person; and
(ii) the offer and sale of the Common Stock issuable by
Shaman to Fletcher on such date does not require registration under the
Securities Act.
d. On each Warrant Exercise Date, Fletcher shall have delivered
to Shaman a legal opinion of Rogers & Wells, counsel to Fletcher, dated
the date of delivery, stating that:
(i) Fletcher is not a U.S. Person; and
(ii) the offer and sale of the Warrant Shares issuable by
Shaman to Fletcher on such date does not require registration under the
Securities Act.
e. On the date of any transfer by Fletcher of any Preferred
Share or the Warrant or any Common Stock during the applicable Restricted
Period, Fletcher shall have delivered to Shaman or its transfer agent, as
the case may be, a legal opinion of Rogers & Wells, dated the date of such
transfer, stating that such transfer complies with the requirements of
Regulation S.
9. Fees and Expenses. Each of Fletcher and Shaman agrees to pay its
own expenses incident to the performance of its obligations hereunder,
including, but not limited to, the fees, expenses and disbursements of such
party's counsel.
14.
<PAGE> 15
10. Non-Performance.
a. If, on the Closing Date or any portion of the Warrant
Exercise Date (as defined in Annex B hereto), Shaman shall fail to deliver
the Preferred Shares, Warrant Shares or Common Stock to Fletcher required
to be delivered pursuant to this Agreement for any reason other than the
failure of any condition precedent to Shaman's obligations hereunder or
the failure by Fletcher to comply with its obligations hereunder, then
Shaman shall:
(1) hold Fletcher harmless against any loss, claim or damage
arising from or as a result of such failure by Shaman; and
(2) reimburse Fletcher for all of its out-of-pocket
expenses, including fees and disbursements of its counsel, incurred by
Fletcher in connection with this Agreement and the transactions
contemplated herein;
provided, however, that Shaman shall then be under no further liability to
Fletcher except as provided in this Section 10 and Section 11 hereof.
b. If, on the Closing Date or any Put Option Exercise Date,
Fletcher shall fail to purchase the Preferred Shares, the Warrant or any
Common Stock required to be purchased pursuant to this Agreement for any
reason other than the failure of any condition precedent to Fletcher's
obligations hereunder or the failure by Shaman to comply with its
obligations hereunder, then Fletcher shall:
(1) hold Shaman harmless against any damage arising from or
as a result of such failure by Fletcher;
(2) reimburse Shaman for all of its out-of-pocket expenses,
including fees and disbursements of its counsel, incurred by Shaman in
connection with this Agreement and the transactions contemplated
herein; and
(3) surrender to Shaman for cancellation any portion of the
Warrant not exercised prior to the date of such default by Fletcher;
provided, however, that Fletcher shall then be under no further liability to
Shaman except as provided in this Section 10 and Section 11 hereof.
11. Indemnification.
a. Indemnification of Fletcher. Shaman hereby agrees to
indemnify Fletcher and each of its officers, directors, employees, agents
and affiliates and each person that controls (within the meaning of
Section 20 of the Securities Exchange Act of 1934, as amended) any of the
foregoing persons (each a "Fletcher Indemnified Party")
15.
<PAGE> 16
against any claim, demand, action, liability, damages, loss, cost or
expense (including, without limitation, reasonable legal fees) (a
"Proceeding"), that it may incur in connection with any of the
transactions contemplated hereby arising out of or based upon:
(1) any untrue or alleged untrue statement of a material fact
by Shaman or any of its affiliates or any person acting on its or their
behalf or omission or alleged omission by Shaman or any of its
affiliates or any person acting on its or their behalf to state any
material fact necessary in order to make the statements, in the light
of the circumstances under which they were made, not misleading;
(2) any of the representations or warranties made by Shaman
herein being untrue or incorrect; and
(3) any breach or non-performance by Shaman of any of its
covenants, agreements or obligations under this Agreement;
and Shaman hereby agrees to reimburse each Fletcher Indemnified Party for
any reasonable legal or other expenses incurred by such Fletcher
Indemnified Party in investigating or defending any such Proceeding;
provided, however, that the foregoing indemnity shall not apply to any
Proceeding to the extent that it arises out of or is based upon the gross
negligence of Fletcher in connection therewith.
b. Indemnification of Shaman. Fletcher hereby agrees to
indemnify Shaman and each of its officers, directors, employees, agents
and affiliates and each person that controls (within the meaning of
Section 20 of the Securities Exchange Act of 1934, as amended) any of the
foregoing persons (each a "Shaman Indemnified Party") against any
Proceeding, that it may incur in connection with any of the transactions
contemplated hereby arising out of or based upon:
(1) any untrue or alleged untrue statement of a material fact
by Fletcher or any of its affiliates or any person acting on its or
their behalf or omission or alleged omission by Fletcher or any of its
affiliates or any person acting on its or their behalf to state any
material fact necessary in order to make the statements, in the light
of the circumstances under which they were made, not misleading;
(2) any of the representations or warranties made by Fletcher
herein being untrue or incorrect; and
(3) any breach or non-performance by Fletcher of any of its
covenants, agreements or obligations under this Agreement;
16.
<PAGE> 17
and Fletcher hereby agrees to reimburse each Shaman Indemnified Party for
any reasonable legal or other expenses incurred by such Shaman Indemnified
Party in investigating or defending any such Proceeding;
provided, however, that the foregoing indemnity shall not apply to any
Proceeding to the extent that it arises out of or is based upon the gross
negligence of Shaman in connection therewith.
c. Conduct of Claims.
(1) Whenever a claim for indemnification shall arise under
this Section , the party seeking indemnification (the "Indemnified
Party"), shall notify the party from whom such indemnification is
sought (the "Indemnifying Party") in writing of the Proceeding and the
facts constituting the basis for such claim in reasonable detail;
(2) Upon delivery of such notice, such Indemnified Party
shall have a duty to take all reasonable steps to mitigate any losses,
liabilities, costs, charges and expenses relating to any such
Proceeding;
(3) Such Indemnifying Party shall have the right to retain
the counsel of its choice in connection with such Proceeding and to
participate at its own expense in the defense of any such Proceeding;
provided, however, that counsel to the Indemnifying Party shall not
(except with the consent of the relevant Indemnified Party) also be
counsel to such Indemnified Party. In no event shall the Indemnifying
Party be liable for fees and expenses of more than one counsel (in
addition to any local counsel) separate from its own counsel for all
Indemnified Parties in connection with any one action or separate but
similar or related actions in the same jurisdiction arising out of the
same general allegations or circumstances; and
(4) No Indemnifying Party shall, without the prior written
consent to the Indemnified Parties (which consent shall not be
unreasonably withheld), settle or compromise or consent to the entry of
any judgment with respect to any litigation, or any investigation or
proceeding by any governmental agency or body, commenced or threatened,
or any claim whatsoever in respect of which indemnification could be
sought under this Section unless such settlement, compromise or consent
(A) includes an unconditional release of each Indemnified Party from
all liability arising out of such litigation, investigation, proceeding
or claim and (B) does not include a statement as to or an admission of
fault, culpability or a failure to act by or on behalf of any
Indemnified Party.
12. Survival of the Representations, Warranties, etc. The respective
representations, warranties and agreements made herein by or on behalf of the
parties hereto
17.
<PAGE> 18
shall remain in full force and effect, regardless of any investigation made by
or on behalf of the other party to this Agreement or any officer, director or
employee of, or person controlling or under common control with, such party and
will survive delivery of and payment for the Preferred Shares, the Warrant and
any Common Stock issuable hereunder.
13. Notices. All communications hereunder shall be in writing, and
a. if sent to Fletcher, shall be delivered by hand, sent by
registered mail or transmitted by telecopy and confirmed to Fletcher at:
Fletcher International Limited
c/o Midland Bank Trust Corporation (Cayman) Limited
P.O. Box 1109, Mary Street
Grand Cayman, Cayman Islands
British West Indies
Telephone: (809) 949-7755
Facsimile: (809) 949-7634
with a copy to:
Rogers & Wells
200 Park Avenue
New York, NY 10166
Attention: Lucien A. Moolenaar III
Telephone: (212) 878-8000
Facsimile: (212) 878-8375
b. if sent to Shaman, shall be delivered by hand, sent by
registered mail or transmitted by telecopy and confirmed to Shaman at:
Shaman Pharmaceuticals, Inc.
213 East Grand Avenue
South San Francisco, CA 94080
Attention: President and Chief Executive Officer
Telephone: (415) 952-7070
Telefax number: (415) 873-8367
18.
<PAGE> 19
with a copy to:
Brobeck, Phleger & Harrison LLP
Two Embarcadero Place
2200 Geng Road
Palo Alto, CA 94303
Attention: J. Stephan Dolezalek
Telephone: (415) 496-2842
Telefax number: (415) 496-2736
14. Miscellaneous.
a. This Agreement may be executed in one or more counterparts
and it is not necessary that signatures of all parties appear on the same
counterpart, but such counterparts together shall constitute but one and
the same agreement.
b. This Agreement shall inure to the benefit of and be binding
upon the parties hereto, their respective successors and, with respect to
Section 11 hereof, their respective officers, directors and affiliates,
and no other person shall have any right or obligation hereunder.
c. This Agreement shall be governed by, and construed in
accordance with, the internal laws of the State of New York, and each of
the parties hereto hereby submits to the non-exclusive jurisdiction of any
State or Federal court in the Borough of Manhattan in the City and State
of New York and any court hearing any appeal therefrom, over any suit,
action or proceeding against it arising out of or based upon this
Agreement (a "Related Proceeding"). Each of the parties hereto hereby
waives any objection to any Related Proceeding in such courts whether on
the grounds of venue, residence or domicile or on the ground that the
Related Proceeding has been brought in an inconvenient forum.
d. The provisions of this Agreement are severable, and if any
clause or provision hereof shall be held invalid, illegal or unenforceable
in whole or in part, such invalidity or unenforceability shall not in any
manner affect any other clause or provision of this Agreement.
e. The headings of the sections of this document have been
inserted for convenience of reference only and shall not be deemed to be a
part of this Agreement.
19.
<PAGE> 20
15. Time of Essence. Time shall be of the essence in this Agreement.
IN WITNESS WHEREOF, the parties hereto have duly executed and delivered
this Agreement, all as of the day and year first above written.
SHAMAN PHARMACEUTICALS, INC.
By: /s/ Lisa A. Conte
--------------------------------------
Name: Lisa A. Conte
Title: President and Chief Executive Office
FLETCHER INTERNATIONAL LIMITED
By: /s/ Alphonse Fletcher, Jr.
--------------------------------------
Name: Alphonse Fletcher, Jr.
Title: Chief Executive Office
20.
<PAGE> 21
ANNEX A
TERMS OF PUT OPTIONS
GRANTED BY FLETCHER INTERNATIONAL LIMITED
TO SHAMAN PHARMACEUTICALS, INC.
The Put Options granted by Fletcher International Limited ("Fletcher")
to Shaman Pharmaceuticals, Inc. ("Shaman") pursuant to the Subscription
Agreement dated July 25, 1996 between Fletcher and Shaman (the "Subscription
Agreement"), including any additional Put Options granted pursuant to Paragraph
4 hereof, shall have the terms and conditions set forth below.
This Annex A forms a part of the Subscription Agreement, and the
following terms and conditions are subject to the representations, warranties
and agreements and further provisions contained in the Subscription Agreement.
Unless otherwise defined herein, capitalized terms used herein shall have the
meanings set forth in the Subscription Agreement.
1. Option to Sell
Each of the Put Options granted pursuant to the Subscription Agreement
shall entitle Shaman to sell to Fletcher and obligate Fletcher to purchase from
Shaman, upon the terms and conditions set forth in the Subscription Agreement
and herein, 200,000 newly issued shares of Common Stock, subject to adjustment
as provided in Paragraph 4 hereof (the "Put Option Amount"), at the price per
share (the "Put Option Price") computed as set forth below.
2. Exercisable by Shaman
The Put Options shall be exercisable only by Shaman and only upon the
terms and conditions and subject to the limitations set forth in the
Subscription Agreement and herein, and the Put Options may not be transferred,
sold, pledged, assigned or otherwise disposed of to any person.
3. Certain Restrictions on Exercise
(a) The Put Options shall be exercisable on any Trading Day (each, a
"Put Option Exercise Date") from but excluding January 27,1997 to and including
July 28, 2000 (the "Put Option Termination Date");
provided, however that, subject to the provisions of Section 3(q) of the
Subscription Agreement, not more than one Put Option shall be exercisable within
any six-month period; and provided
<PAGE> 22
further, however, that no Put Option shall be exercisable unless Shaman shall
have delivered to Fletcher on the relevant Put Option Exercise Date a
certificate of the Chief Executive Officer and Chief Financial Officer of
Shaman, dated such Put Option Exercise Date, confirming that each of the
representations and warranties made by Shaman in the Subscription Agreement are
true and correct as of such Put Option Exercise Date. Notwithstanding anything
to the contrary contained herein or in the Subscription Agreement, in no event
shall any Put Option be exercisable to the extent that (i) the number of shares
of Common Stock issuable to Fletcher pursuant to such Put Option plus (ii) the
number of shares of Common Stock previously issued to Fletcher pursuant to any
Put Option plus (iii) the total number of shares of Common Stock issuable to
Fletcher pursuant to the Preferred Shares (whether or not such Preferred Shares
have then been converted) plus (iv) the total number of Warrant Shares issuable
to Fletcher pursuant to the Agreement (whether or not such Warrant Shares have
then been issued), would equal or exceed 2,677,500 shares.
(b) On any Put Option Settlement Date (as defined below), the Put
Option Price payable by Fletcher shall be (i) 101 percent of the Weighted
Average Price (as hereinafter defined) during the period (the "Original Pricing
Period") from but excluding the second Trading Day after the relevant Put Option
Exercise Date and to and including the * * * Day thereafter, or (ii) if written
notice is given by Fletcher at any time after the fifth day of any Pricing
Period but prior to the end of such Pricing Period, the Weighted Average Price
(as hereinafter defined) during the period (the "Adjusted Pricing Period") from
but excluding the * * * Day prior to such Put Option Exercise Date to and
including such Put Option Exercise Date. "Weighted Average Price" shall mean,
with respect to any specified time period, the arithmetic average of the daily
volume-weighted average sale prices (rounded to the nearest tenth of a cent) of
the Shaman Common Stock on NASDAQ, as reported by Bloomberg L.P., or, if
Bloomberg, L.P. is not then reporting such information, any successor service
mutually agreed upon by Shaman and Fletcher. [* INDICATES THAT MATERIAL HAS BEEN
OMITTED AND CONFIDENTIAL TREATMENT HAS BEEN REQUESTED THEREFOR. ALL SUCH OMITTED
MATERIAL HAS BEEN FILED SEPARATELY WITH THE COMMISSION PURSUANT TO RULE 24b-2.]
4. Additional Put Options
Fletcher shall have the right (on the Business Day immediately prior to
each Put Right Closing Date, as defined below) to increase the applicable Put
Option Amount to a maximum of 400,000 shares of Common Stock or to reduce the
applicable Put Option Amount to a minimum of four times the average of the daily
volume of shares of Common Stock traded on the Nasdaq Stock Market during the
applicable Original Pricing Period or Adjusted Pricing Period, as the case may
be. The excess, if any, of the original Put Option Amount over such decreased
Put Option Amount shall be referred to herein as the "Remaining Shares". If
Fletcher does reduce the Put Option Amount in one or more instances, Shaman will
receive that number of additional Put Options on a cumulative basis equal to the
total number of Remaining Shares divided by 200,000, plus an additional Put
Option for any fractional remainder of the Remaining Shares (exercisable only to
the extent of the number of Remaining Shares in such fractional
2.
<PAGE> 23
remainder).
5. Certain Exercise Procedures
On any Put Option Exercise Date, Shaman may exercise a Put Option by
delivering notice thereof to Fletcher in accordance with the Subscription
Agreement. On the second Business Day following (i) the end of the Original
Pricing Period or (ii) the date on which Fletcher exercises its right to
calculate the put option price using the Adjusted Pricing Period, as the case
may be, or such later date as shall be agreed by Shaman and Fletcher (a "Put
Option Settlement Date"), Shaman shall issue to Fletcher the number of shares of
Common Stock equal to the Put Option Amount calculated as provided herein
against payment by Fletcher of the Put Option Price in New York Clearing House
(next day) funds in accordance with the Subscription Agreement.
6. Expiration and Termination
(a) Any Put Option (including any additional Put Options granted
pursuant to Paragraph 4 hereof) that has not been exercised by Shaman in
accordance with the terms of the Subscription Agreement and hereof by 5:00 p.m.
(New York time) on the Put Option Termination Date shall immediately expire and
not thereafter be exercisable, and Fletcher shall have no further obligation
whatsoever with respect to any such Put Option.
3.
<PAGE> 24
The Warrant represented by this certificate was issued on July 26, 1996
(the "Original Issue Date") pursuant to the Subscription Agreement
dated July 25, 1996 between Shaman Pharmaceuticals, Inc. and Fletcher
International Limited. Neither the Warrant represented by this
certificate nor the securities issuable upon exercise hereof have been
registered under the Securities Act of 1933, as amended (the "Act").
The Warrant represented hereby has been sold in reliance on the
exemption from registration provided by Regulation S under the Act
("Regulation S"). Prior to the expiration of a 40-day restricted period
beginning on the Original Issue Date (the "Restricted Period"), the
Warrant represented by this certificate may not be exercised, offered
or sold, directly or indirectly, within the United States (as defined
in Regulation S under the Act), to a U.S. Person (as defined in
Regulation S under the Act) or for the account or benefit of a U.S.
Person. Neither Shaman Pharmaceuticals, Inc. nor its transfer agent
shall be obligated to remove this legend unless it shall have received
an opinion of counsel stating that such removal complies with the
requirements of Regulation S.
WARRANT NO. _________________ 550,000 WARRANT SHARES
WARRANT CERTIFICATE
SHAMAN PHARMACEUTICALS, INC.
This Warrant Certificate certifies that FLETCHER INTERNATIONAL LIMITED,
or registered assigns, is the registered holder of one Warrant (the "Warrant")
expiring on the Termination Date (as defined below) to purchase up to 550,000
shares (the "Warrant Shares") of common stock, par value $.001 per share (the
"Common Stock"), of Shaman Pharmaceuticals, Inc., a Delaware corporation (the
"Issuer"), at the Exercise Price (as defined below).
The Warrant represented hereby was issued on July 26, 1996 (the
"Original Issue Date") pursuant to the Subscription Agreement dated July 25,
1996 (the "Subscription Agreement"), between the Issuer and Fletcher
International Limited ("Fletcher"), and is subject to the terms and conditions
thereof. Unless otherwise defined herein, capitalized terms used herein shall
have the meanings set forth in the Subscription Agreement. A copy of the
Subscription Agreement may be obtained by the registered holder hereof upon
written request to the Issuer.
The Warrant represented hereby may be exercised on any Business Day (a
"Warrant Exercise Date") from but excluding the Original Issue Date to and
including July 25, 2002 (the "Termination Date"). The Warrant entitles the
registered holder hereof to receive from the Issuer upon exercise up to the
number of Warrant Shares set forth on the face hereof upon
<PAGE> 25
surrender of this Warrant Certificate as provided on the reverse hereof and
payment of the Exercise Price defined below (the "Exercise Price") (plus
transfer taxes, if applicable) to the Issuer in cash or by certified or official
bank check.
The Exercise Price per Warrant Share shall be $10.184.
The Warrant represented hereby shall have the following additional
terms:
1. The Warrant represented hereby may be exercised upon surrender of this
Warrant Certificate by the registered holder hereof to the Issuer at its
principal office on any Exercise Date with the Exercise Notice attached
hereto (an "Exercise Notice") duly completed and signed by the registered
holder hereof and upon payment by such holder to the Issuer of the Exercise
Price (plus transfer taxes, if applicable) for the total number of Warrant
Shares in respect of which such Warrant is then exercised. The Warrant
represented hereby shall be exercisable only in the minimum amount of
30,000 Warrant Shares and integral multiples of 30,000 Warrant Shares in
excess thereof (or such lesser amount as shall constitute the full amount
of this Warrant).
2. On the Business Day following an Exercise Date (an "Issue Date") the Issuer
shall issue and cause to be delivered to the registered holder hereof at
such address as such holder shall specify in the Exercise Notice a
certificate or certificates for the number of full Warrant Shares issuable
upon the exercise of such Warrant, registered in such holder's name,
together with cash (if any) as provided in paragraph 4. Such certificate or
certificates shall be deemed to have been issued and any person so
designated to be named therein shall be deemed to have become a holder of
record of such Warrant Shares as of such Exercise Date.
3. If on such Issue Date the number of Warrant Shares to be delivered shall be
less than the total number of Warrant Shares deliverable hereunder, there
shall be issued to the holder hereof or his assignee on such Issue Date a
new warrant certificate substantially identical to this Warrant
Certificate, except that such new warrant certificate shall evidence the
right to purchase the number of Warrant Shares equal to (x) the total
number of Warrant Shares deliverable hereunder less (y) the number of
Warrant Shares so delivered.
4. The Issuer shall not be required to issue fractional Warrant Shares on the
exercise of the Warrant represented hereby. The number of full Warrant
Shares which shall be issuable upon the exercise of the Warrant shall be
computed on the basis of the aggregate number of Warrant Shares purchasable
on exercise of the Warrant so presented. If any fraction of a Warrant Share
would, except for the provisions of this paragraph 4, be issuable on the
exercise of the Warrant, the Issuer shall pay an amount in cash equal to
the closing sale price of the Common Stock per Warrant Share on the day
immediately preceding the date the Warrant is presented for exercise,
multiplied by such fraction.
5. For so long as the Warrant represented hereby has not been exercised in
full, the Issuer shall at all times reserve and keep available, free from
preemptive rights, out of its
2.
<PAGE> 26
authorized but unissued Common Stock, for issuance upon exercise of the
Warrant represented hereby, the maximum number of Common Stock then so
issuable (as adjusted from time to time pursuant to paragraph 10).
6. By accepting delivery of this Warrant Certificate, the registered holder
hereby covenants and agrees with the Issuer not to exercise or transfer the
Warrant represented hereby except in compliance with the terms of the
Subscription Agreement and this Warrant Certificate.
7. By accepting delivery of this Warrant Certificate, the registered holder
hereof covenants and agrees with the Issuer that no Warrant may be sold,
assigned, conveyanced, pledged, hypothecated or in any other manner
disposed of or transferred unless and until such holder shall deliver to
the Issuer (i) written notice of such transfer and of the name and address
of the transferee has been received by the Issuer; (ii) a written agreement
of the transferee to comply with the terms of the Subscription Agreement
and this Warrant Certificate and (iii) in the case of a transfer hereof
prior to the expiration of the Restricted Period specified on the first
page hereof, an opinion of counsel stating that such transferee is not a
"U.S. Person" as defined in Regulation S under the Securities Act of 1933,
as amended, and that such transfer is otherwise exempt from any
registration requirements.
8. The Issuer will pay all documentary stamp taxes (if any) attributable to
the issuance of Warrant Shares upon the exercise of the Warrant by the
registered holder hereof; provided, however, that the Issuer shall not be
required to pay any tax or taxes which may be payable in respect of any
transfer involved in the registration of the Warrant Certificate or any
certificates for Warrant Shares in a name other than that of the registered
holder of the Warrant Certificate surrendered upon the exercise of a
Warrant, and the Issuer shall not be required to issue or deliver the
Warrant Certificate or certificates for Warrant Shares unless or until the
person or persons requesting the issuance thereof shall have paid to the
Issuer the amount of such tax or shall have established to the satisfaction
of the Issuer that such tax has been paid.
9. In case this Warrant Certificate shall be mutilated, lost, stolen or
destroyed, the Issuer may in its discretion issue in exchange and
substitution for and upon cancellation of the mutilated Warrant
Certificate, or in lieu of and substitution for the Warrant Certificate
lost, stolen or destroyed, a new Warrant Certificate of like tenor, but
only upon receipt of evidence reasonably satisfactory to the Issuer of such
loss, theft or destruction of such Warrant Certificate and indemnity, if
requested, satisfactory to it. Applicants for a substitute Warrant
Certificate shall also comply with such other reasonable regulations and
pay such other reasonable charges as the Issuer may prescribe.
10. The number of Warrant Shares issuable upon the exercise of the Warrant (the
"Exercise Rate") and the terms and conditions of the Warrant are subject to
adjustment by the Issuer, in consultation with the holder hereof, from time
to time as follows:
3.
<PAGE> 27
a. If the Issuer:
(1) subdivides its outstanding shares of Common Stock into a greater
number of shares;
(2) combines its outstanding shares of Common Stock into a smaller
number of shares; or
(3) issues by reclassification of its Common Stock any shares of its
Capital Stock (as defined below);
then the Exercise Rate in effect immediately prior to such action
shall be adjusted so that the registered holder hereof shall
thereafter be entitled to receive upon exercise the number of shares
of Common Stock or other Capital Stock of the Issuer which such holder
would have owned immediately following such action if such holder had
exercised the Warrant immediately prior to such action.
As used herein the term "Capital Stock" means, with respect to any
corporation, any and all shares, interest, rights to purchase,
warrants, options, participations or other equivalents of or interests
(however designated) in stock issued by that corporation.
Such adjustment shall become effective simultaneously with the
effective date of any subdivision, combination or reclassification.
If, after an adjustment, the registered holder hereof would receive
upon exercise shares of two or more classes of Capital Stock of the
Issuer, the Exercise Rate shall thereafter be subject to adjustment
upon the occurrence of an action taken with respect to each such class
of Capital Stock as is contemplated hereby with respect to the Common
Stock, on terms comparable to those applicable to Common Stock
hereunder.
b. Whenever the Exercise Rate is adjusted, the Issuer shall provide the
notices required by paragraph 12 hereof.
c. If:
(1) the Issuer takes any action that would require an adjustment in
the Exercise Rate pursuant to subparagraph (a) above; or
(2) there is a liquidation or dissolution of the Issuer;
then the Issuer shall mail to the registered holder hereof a notice
stating the proposed effective date of a subdivision, combination,
reclassification, consolidation, merger, transfer, lease, liquidation
or dissolution, as the case may
4.
<PAGE> 28
be. The Issuer shall mail the notice at least 15 days before such
date.
d. The Issuer covenants and agrees with the registered holder hereof not
to consolidate or merge with or into, or transfer or lease all or
substantially all its assets to, any person unless, at the option of
the registered holder hereof, either:
(1) on any date prior to the effective date of such consolidation,
merger, transfer or lease (the "Redemption Date"), the Issuer
shall have redeemed the Warrant represented hereby by paying to
such holder, upon surrender of this Warrant Certificate, a price
(the "Redemption Price"), agreed in good faith by the Board of
Directors of the Issuer and such holder, representing (x) the
fair market value of the Common Stock that would be issuable upon
exercise of the Warrant as of the Redemption Date; (y) In the
event the fair market value as determined in (x) above is less
than $30.00 a share, the intrinsic time value of the Warrant as
of the Redemption Date, such intrinsic value when added to the
fair market value shall not exceed $30.00 per share and (z) such
other factors as the Board of Directors and such holder deem
appropriate; provided, however, that in the event of any bona
fide dispute between the Issuer and such holder as to the
computation of such Redemption Price, such dispute shall be
resolved through binding arbitration under the rules of the
American Arbitration Association, with the arbitration panel
consisting of persons familiar with the valuation of derivative
securities and such panel being advised, as to such valuation
issues, by an investment bank of nationally recognized standing,
the costs thereof to be borne by the non-prevailing party; or
(2) (a) such person shall expressly assume in writing all of the
obligations of the Issuer under the Subscription Agreement
and hereunder and deliver notice thereof to the registered
holder hereof; and
(b) upon consummation of such transaction, the Warrant shall
automatically become exercisable for the kind and amount of
securities, cash or other assets that the registered holder
hereof would have owned immediately after the consolidation,
merger, transfer or lease if such holder had exercised the
Warrant immediately before the effective date of such
transaction.
e. After an adjustment to the Exercise Rate hereunder, any subsequent
event requiring an adjustment hereunder shall cause an adjustment to
the Exercise Rate as so adjusted.
11. Upon the issuance of any stock dividend or distribution of Common Stock pro
rata to all holders of Common Stock, the registered holder hereof on the
record date for such
5.
<PAGE> 29
distribution shall be entitled to receive such dividend or distribution on
the same terms as the holders of Common Stock upon exercise hereof.
12. Upon any adjustment of the Exercise Rate pursuant to paragraph 10, the
Issuer shall promptly thereafter but in any event within 15 days following
such adjustment (i) cause to be delivered to the registered holder hereof a
certificate of its Chief Financial Officer setting forth the Exercise Rate
after such adjustment and setting forth in reasonable detail the method of
calculation and the facts upon which such calculations are based, which
certificate shall be conclusive evidence of the correctness of the matters
set forth therein, and (ii) cause to be delivered to the registered holder
hereof at his or her address appearing on the Warrant Register written
notice of such adjustments by first-class mail, postage prepaid. Where
appropriate, such notice may be given in advance and included as part of
the notice required to be mailed under the other provisions of this
paragraph 12.
In case:
a. the Issuer shall authorize the issuance to all holders of shares of
Common Stock of rights, options or warrants to subscribe for or
purchase shares of Common Stock or of any other subscription rights or
warrants; or
b. of any consolidation or merger to which the Issuer is a party and for
which approval of any shareholders of the Issuer is required, or of
the conveyance or transfer of the properties and assets of the Issuer
substantially as an entirety, or of any reclassification or change of
Common Stock issuable upon exercise of the Warrant (other than a
change in par value, or from par value to no par value, or from no par
value to par value, or as a result of a subdivision or combination),
or of a tender offer or exchange offer for shares of Common Stock; or
c. of the voluntary or involuntary dissolution, liquidation or winding up
of the Issuer; or
d. the Issuer proposes to take any action which would require an
adjustment of the Exercise Rate pursuant to paragraph 10;
then the Issuer shall cause to be given to the registered holder hereof at
his or her address appearing on the Warrant Register, at least 20 days (or
10 days in any case specified in clauses (a) or (b) above) prior to the
applicable record date hereinafter specified, or promptly in the case of
events for which there is no record date, by first class mail, postage
prepaid, a written notice stating (i) the date as of which the holders of
record of shares of Common Stock to be entitled to receive any such rights,
options, warrants or distribution are to be determined, or (ii) the initial
expiration date set forth in any tender offer or exchange offer for shares
of Common Stock, or (iii) the date on which any such reclassification,
consolidation, merger, conveyance, transfer, dissolution, liquidation or
winding up is expected to become effective or consummated, and the date
6.
<PAGE> 30
as of which it is expected that holders of record of shares of Common Stock
shall be entitled to exchange such shares for securities or other property,
if any, deliverable upon such reclassification, consolidation, merger,
conveyance, transfer, dissolution, liquidation or winding up.
13. The Issuer shall serve as warrant agent (the "Warrant Agent") under this
Agreement. The Warrant Agent hereunder shall at all times maintain a
register (the "Warrant Register") of the holders of Warrants. Upon 30 days'
notice to the registered holder hereof, the Issuer may appoint a new
Warrant Agent. Such new Warrant Agent shall be a corporation doing business
under the laws of the United States or any state thereof, in good standing
and having a combined capital and surplus of not less than $50,000,000. The
combined capital and surplus of any such new Warrant Agent shall be deemed
to be the combined capital and surplus as set forth in the most recent
annual report of its condition published by such Warrant Agent prior to its
appointment; provided that such reports are published at least annually
pursuant to law or to the requirements of a federal or state supervising or
examining authority. After acceptance in writing of such appointment by the
new Warrant Agent, it shall be vested with the same powers, rights, duties
and responsibilities as if it had been originally named herein as the
Warrant Agent, without any further assurance, conveyance, act or deed; but
if for any reason it shall be reasonably necessary or expedient to execute
and deliver any further assurance, conveyance, act or deed, the same shall
be done at the expense of the Issuer and shall be legally and validly
executed and delivered by the Issuer.
Any corporation into which the Issuer or any new Warrant Agent may be
merged or any corporation resulting from any consolidation to which the
Issuer or any new Warrant Agent shall be a party or any corporation to
which the Issuer or any new Warrant Agent transfers substantially all of
its corporate trust or shareholders services business shall be a successor
Warrant Agent under this Agreement without any further act; provided that
such corporation (i) would be eligible for appointment as successor to the
Warrant Agent under the provisions of this paragraph 13 or (ii) is a wholly
owned subsidiary of the Warrant Agent. Any such successor Warrant Agent
shall promptly cause notice of its succession as Warrant Agent to be mailed
(by first class mail, postage prepaid) to the registered holder hereof at
such holder's last address as shown on the Warrant Register.
This Warrant Certificate shall not be valid unless signed by the Issuer.
7.
<PAGE> 31
IN WITNESS WHEREOF, Shaman Pharmaceuticals, Inc. has caused this Warrant
Certificate to be signed by its duly authorized officer.
Dated: July 26, 1996
SHAMAN PHARMACEUTICALS, INC.
By:________________________________
Name: Lisa A. Conte
Title: President and Chief Executive Officer
8.
<PAGE> 32
FORM OF EXERCISE NOTICE
(To Be Executed Upon Exercise Of the Warrant)
[DATE]
Shaman Pharmaceuticals, Inc.
213 East Grand Avenue
South San Francisco, CA 94080
Attn: President and Chief Executive Officer
Re: Warrant No.
Ladies and Gentlemen:
The undersigned is the registered holder of the above-referenced
warrant (the "Warrant") issued by Shaman Pharmaceuticals, Inc., evidenced by the
Warrant Certificate attached hereto, and hereby elects to exercise the Warrant
to purchase _____ shares of Warrant Shares (as defined in such Warrant
Certificate) and herewith tenders $______________ [in cash] [by certified or
official bank check to the order of Shaman Pharmaceuticals, Inc.] as payment for
such Warrant Shares in accordance with the terms of such Warrant Certificate.
In accordance with the terms of the attached Warrant Certificate, the
undersigned requests that certificates for such shares be registered in the name
of and delivered to the undersigned at the following address:(1)
________________________________
________________________________
________________________________
[If the number of Warrant Shares to be delivered is less than the total
number of Warrant Shares deliverable under the Warrant, insert the following -
The undersigned requests that a new warrant certificate substantially identical
to the attached Warrant Certificate be issued to the undersigned evidencing the
right to purchase the number of Warrant Shares equal to (x) the total number of
Warrant Shares deliverable under the Warrant less (y) the number of Warrant
Shares to be delivered in connection with this exercise.
NAME OF REGISTERED HOLDER [ADDRESS]
[ADDRESS]
[ADDRESS]
[ADDRESS]
By: _____________________________________
Name:
Title:
____________________
(1) Prior to the expiration of the Restricted Period (if any) referred to in the
legend appearing on the Warrant Certificate attached hereto, the Warrant Shares
issuable thereunder "shall not be delivered within the United States (as defined
in Regulation S under the Securities Act of 1933, as amended (the "Securities
Act")) unless registered under the Securities Act or pursuant to an available
exemption from such registration.
